Gregory I. Frost
2006
In 2006, Gregory I. Frost earned a total compensation of $335.5K as Vice President and Chief Scientific Officer at Halozyme Therapeutics, a 11% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $31,500 |
|---|---|
| Option Awards | $93,855 |
| Salary | $210,000 |
| Other | $188 |
| Total | $335,543 |
Frost received $210K in salary, accounting for 63% of the total pay in 2006.
Frost also received $31.5K in non-equity incentive plan, $93.9K in option awards and $188 in other compensation.
Rankings
In 2006, Gregory I. Frost's compensation ranked 5,579th out of 7,022 executives tracked by ExecPay. In other words, Frost earned more than 20.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,579 out of 7,022 | 21st |
Division Manufacturing | 1,927 out of 2,413 | 20th |
Major group Chemicals And Allied Products | 534 out of 673 | 21st |
Industry group Drugs | 396 out of 518 | 24th |
Industry Biological Products, Except Diagnostic Substances | 87 out of 112 | 22nd |
Source: SEC filing on April 2, 2009.
Frost's colleagues
We found five more compensation records of executives who worked with Gregory I. Frost at Halozyme Therapeutics in 2006.
2006
Jonathan Lim
Halozyme Therapeutics
Chief Executive Officer
2006
Richard Yocum
Halozyme Therapeutics
Vice President — Clinical Development and Medical Affairs
2006
David Ramsay
Halozyme Therapeutics
Chief Financial Officer
2006
Robert Little
Halozyme Therapeutics
Vice President and Chief Commercial Officer
2006
William Fallon
Halozyme Therapeutics